Turnbull Christopher D, Bratton Daniel J, Craig Sonya E, Kohler Malcolm, Stradling John R
1 Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, UK ; 2 Oxford Biomedical Research Centre, National Institute for Health Research, Oxford, UK ; 3 Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland.
J Thorac Dis. 2016 Feb;8(2):276-81. doi: 10.3978/j.issn.2072-1439.2016.01.54.
Long-term continuous positive airway pressure (CPAP) usage varies between individuals. It would be of value to be able to identify those who are likely to benefit from CPAP (and use it long term), versus those who would not, and might therefore benefit from additional help early on. First, we explored whether baseline characteristics predicted CPAP usage in minimally symptomatic obstructive sleep apnoea (OSA) patients, a group who would be expected to have low usage. Second, we explored if early CPAP usage was predictive of longer-term usage, as has been shown in more symptomatic OSA patients.
The MOSAIC trial was a multi-centre randomised controlled trial where minimally symptomatic OSA patients were randomised to CPAP, or standard care, for 6 months. Here we have studied only those patients randomised to CPAP treatment. Baseline characteristics including symptoms, questionnaires [including the Epworth sleepiness score (ESS)] and sleep study parameters were recorded. CPAP usage was recorded at 2-4 weeks after initiation and after 6 months. The correlation and association between baseline characteristics and 6 months CPAP usage was assessed, as was the correlation between 2 and 4 weeks CPAP usage and 6 months CPAP usage.
One hundred and ninety-five patients randomised to CPAP therapy had median [interquartile range (IQR)] CPAP usage of 2:49 (0:44, 5:13) h:min/night (h/n) at the 2-4 weeks visit, and 2:17 (0:08, 4:54) h/n at the 6 months follow-up visit. Only male gender was associated with increased long-term CPAP use (male usage 2:56 h/n, female 1:57 h/n; P=0.02). There was a moderate correlation between the usage of CPAP at 2-4 weeks and 6 months, with about 50% of the variability in long-term use being predicted by the short-term use.
In patients with minimally symptomatic OSA, our study has shown that male gender (and not OSA severity or symptom burden) is associated with increased long-term use of CPAP at 6 months. Although, in general, early patterns of CPAP usage predicted longer term use, there are patients in whom this is not the case, and patients with low initial usage may need to extend their CPAP trial before a decision about longer-term use is made.
长期持续气道正压通气(CPAP)的使用情况因人而异。能够识别出那些可能从CPAP中获益(并长期使用)的人,以及那些不会获益、因此可能早期就需要额外帮助的人,将具有重要价值。首先,我们探讨了基线特征是否能预测症状轻微的阻塞性睡眠呼吸暂停(OSA)患者的CPAP使用情况,这类患者预计CPAP使用率较低。其次,我们探讨了早期CPAP使用是否能预测长期使用情况,这在症状更明显的OSA患者中已得到证实。
MOSAIC试验是一项多中心随机对照试验,将症状轻微的OSA患者随机分为CPAP组或标准治疗组,为期6个月。在此我们仅研究那些随机接受CPAP治疗的患者。记录了包括症状、问卷[包括爱泼沃斯思睡量表(ESS)]和睡眠研究参数在内的基线特征。在开始治疗后2 - 4周和6个月时记录CPAP使用情况。评估了基线特征与6个月CPAP使用情况之间的相关性和关联性,以及2 - 4周CPAP使用情况与6个月CPAP使用情况之间的相关性。
195名随机接受CPAP治疗的患者在2 - 4周访视时CPAP使用的中位数[四分位间距(IQR)]为2:49(0:44,5:13)小时:分钟/晚(h/n),在6个月随访时为2:17(0:08,4:54)h/n。只有男性性别与长期CPAP使用增加相关(男性使用量为2:56 h/n,女性为1:57 h/n;P = 0.02)。2 - 4周时CPAP使用情况与6个月时的使用情况之间存在中度相关性,长期使用情况中约50%的变异性可由短期使用情况预测。
在症状轻微的OSA患者中,我们的研究表明男性性别(而非OSA严重程度或症状负担)与6个月时CPAP的长期使用增加相关。尽管一般来说,早期CPAP使用模式可预测长期使用情况,但也有患者并非如此,初始使用量低的患者在做出长期使用决策之前可能需要延长CPAP试验期。